Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
TWX
Time Warner Inc
TWX
|
$1.01B |
| 2 |
Johnson Controls International
JCI
|
$683M |
| 3 |
Nutrien
NTR
|
$582M |
| 4 |
VMW
VMware, Inc
VMW
|
$397M |
| 5 |
Wells Fargo
WFC
|
$351M |
Top Sells
| 1 |
NetApp
NTAP
|
$708M |
| 2 |
AGU
Agrium
AGU
|
$635M |
| 3 |
Walmart
WMT
|
$508M |
| 4 |
Target
TGT
|
$437M |
| 5 |
UnitedHealth
UNH
|
$430M |
Sector Composition
| 1 | Financials | 25.08% |
| 2 | Healthcare | 19.03% |
| 3 | Communication Services | 16.65% |
| 4 | Technology | 14% |
| 5 | Energy | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$248B
| $1.91B | 1.54% |
54,530,179
-2,000,800
| -4% | -$70M |
|
27
GSK
GSK
$79.9B
| $1.9B | 1.53% |
48,551,967
+4,468,674
| +10% | +$175M |
|
28
HP
HPQ
$26.7B
| $1.81B | 1.46% |
82,757,309
-1,483,488
| -2% | -$32.5M |
|
29
Union Pacific
UNP
$133B
| $1.78B | 1.43% |
13,217,459
-264,120
| -2% | -$35.5M |
|
30
Bristol-Myers Squibb
BMY
$96B
| $1.76B | 1.42% |
27,817,611
-1,288,500
| -4% | -$81.5M |
|
31
Cigna
CI
$80.3B
| $1.74B | 1.41% |
10,401,022
-333,571
| -3% | -$56M |
|
32
Eli Lilly
LLY
$657B
| $1.69B | 1.36% |
21,842,117
+1,660,830
| +8% | +$128M |
|
|
33
UnitedHealth
UNH
$281B
| $1.59B | 1.28% |
7,406,972
-2,010,650
| -21% | -$430M |
|
34
Booking.com
BKNG
$181B
| $1.52B | 1.23% |
731,030
-33,005
| -4% | -$68.7M |
|
35
Medtronic
MDT
$119B
| $1.5B | 1.21% |
18,721,632
+436,874
| +2% | +$35M |
|
36
APA Corp
APA
$8.31B
| $1.42B | 1.15% |
36,978,997
+5,635,752
| +18% | +$217M |
|
37
Suncor Energy
SU
$50.1B
| $1.41B | 1.14% |
40,909,500
-159,400
| -0.4% | -$5.51M |
|
38
NOV
NOV
$4.94B
| $1.19B | 0.96% |
32,445,864
+1,271,625
| +4% | +$46.8M |
|
39
Liberty Global Class C
LBTYK
$4.07B
| $1.17B | 0.94% |
38,439,605
+893,700
| +2% | +$27.2M |
|
40
Gilead Sciences
GILD
$140B
| $1.16B | 0.94% |
15,445,461
+29,100
| +0.2% | +$2.19M |
|
41
Celanese
CE
$5.22B
| $1.07B | 0.86% |
10,679,400
-282,770
| -3% | -$28.3M |
|
42
Dell
DELL
$82.6B
| $1.04B | 0.84% |
14,211,436
-67,569
| -0.5% | -$4.95M |
|
43
Baker Hughes
BKR
$44.8B
| $1.03B | 0.83% |
37,059,953
+4,631,493
| +14% | +$129M |
|
|
MXIM
44
DELISTED
Maxim Integrated Products
MXIM
| $1.02B | 0.82% |
16,868,114
-916,350
| -5% | -$55.2M |
|
45
Truist Financial
TFC
$60.4B
| $984M | 0.79% |
18,917,798
-924,140
| -5% | -$48.1M |
|
|
46
Target
TGT
$43.6B
| $956M | 0.77% |
13,770,640
-6,298,661
| -31% | -$437M |
|
|
JNPR
47
DELISTED
Juniper Networks
JNPR
| $950M | 0.77% |
39,053,157
+2,960,300
| +8% | +$72M |
|
48
Televisa
TV
$1.49B
| $917M | 0.74% |
57,436,661
+10,102,686
| +21% | +$161M |
|
49
JD.com
JD
$44.1B
| $874M | 0.71% |
21,593,992
-6,117,299
| -22% | -$248M |
|
|
QVCGA
50
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $854M | 0.69% |
33,941,808
-642,100
| -2% | -$16.2M |
|